Tags

Type your tag names separated by a space and hit enter

COVID-19 coagulopathy: an evolving story.
Lancet Haematol. 2020 06; 7(6):e425.LH

Links

PMC Free PDF

Authors

The Lancet Haematology
No affiliation info available

MeSH

AnticoagulantsAntiviral AgentsBetacoronavirusBlood CoagulationCOVID-19Coronavirus InfectionsCritical IllnessDisseminated Intravascular CoagulationFibrin Fibrinogen Degradation ProductsHumansInflammationPandemicsPneumonia, ViralSARS-CoV-2ThromboembolismThrombosis

Pub Type(s)

Editorial

Language

eng

PubMed ID

32470428

Clinical Trial Links

Extracorporeal Blood Purification as a Treatment Modality for COVID-19

Citation

The Lancet Haematology, . "COVID-19 Coagulopathy: an Evolving Story." The Lancet. Haematology, vol. 7, no. 6, 2020, pp. e425.
The Lancet Haematology . COVID-19 coagulopathy: an evolving story. Lancet Haematol. 2020;7(6):e425.
The Lancet Haematology, . (2020). COVID-19 coagulopathy: an evolving story. The Lancet. Haematology, 7(6), e425. https://doi.org/10.1016/S2352-3026(20)30151-4
The Lancet Haematology . COVID-19 Coagulopathy: an Evolving Story. Lancet Haematol. 2020;7(6):e425. PubMed PMID: 32470428.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - COVID-19 coagulopathy: an evolving story. A1 - The Lancet Haematology,, PY - 2020/5/30/pubmed PY - 2020/6/10/medline PY - 2020/5/30/entrez SP - e425 EP - e425 JF - The Lancet. Haematology JO - Lancet Haematol VL - 7 IS - 6 SN - 2352-3026 UR - https://www.unboundmedicine.com/medline/citation/32470428/COVID_19_coagulopathy:_an_evolving_story_ DB - PRIME DP - Unbound Medicine ER -